Literature DB >> 21353002

Sternal wound infections in pediatric congenital cardiac surgery: a survey of incidence and preventative practice.

Cathy S Woodward1, Minnette Son, John Calhoon, Joel Michalek, S Adil Husain.   

Abstract

BACKGROUND: Guidelines exist for prevention of sternal wound infections (SWI) in adults. There are no guidelines for pediatric patients and limited reports on SWI incidence. The purpose of this study was to determine the incidence of, and preventative practice regarding pediatric SWIs with a long-term aim to develop best practice guidelines.
METHODS: Eighty-nine congenital heart programs were sent a 31 question on-line survey regarding pediatric SWI.
RESULTS: Thirty eight (43%) of the 89 programs responded. They reported 8,774 pediatric congenital procedures with a mean SWI rate of 1.53% (range, 0 to 9.09). Mean yearly volume was 237 operations (range, 50 to 720). Neither program size nor delayed sternal closure was associated with increased incidence of SWI. Variations in preoperative measures, antibiotic regimens, and wound care did not statistically impact incidence of SWI. Programs with protocols to monitor and control blood glucose levels postoperatively had statistically lower infection rates (1.04 vs 2.35, p = 0.03), and those that sent mediastinal cultures at time of delayed sternal closure reported lower infection rates (1.34 vs 1.74, p = 0.051).
CONCLUSIONS: This report provides a multiinstitutional SWI incidence from pediatric programs of 1.53%. Despite variations in clinical practice between programs, this survey revealed two strategies resulting in reduced SWIs; protocol-based management of glucose levels and mediastinal wound cultures sent at time of closure. Pediatric programs do not consistently follow adult preventative guidelines. Multicenter randomized research is needed to formulate preventative guidelines to reduce the incidence of pediatric SWI.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21353002     DOI: 10.1016/j.athoracsur.2010.10.030

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Impact of the implementation of an interdisciplinary infection control program to prevent surgical wound infection in pediatric heart surgery.

Authors:  Jaume Izquierdo-Blasco; Magda Campins-Martí; Pere Soler-Palacín; Joan Balcells; Raul Abella; Ferran Gran; Félix Castillo; Rosario Nuño; Joan Sanchez-de-Toledo
Journal:  Eur J Pediatr       Date:  2015-02-05       Impact factor: 3.183

2.  Commentary: Small patients with big wounds.

Authors:  Andrew M Young; Anthony V Norman; Irving L Kron
Journal:  J Card Surg       Date:  2022-08-18       Impact factor: 1.778

3.  Implementing a standardized perioperative antibiotic prophylaxis protocol for neonates undergoing cardiac surgery.

Authors:  Meghan T Murray; Rozelle Corda; Rebecca Turcotte; Emile Bacha; Lisa Saiman; Ganga Krishnamurthy
Journal:  Ann Thorac Surg       Date:  2014-07-16       Impact factor: 4.330

4.  Colonization of multidrug resistant pathogens in a hybrid pediatric cardiac surgery center.

Authors:  Radoslaw Jaworski; Ireneusz Haponiuk; Mariusz Steffens; Elzbieta Arlukowicz; Ninela Irga-Jaworska; Maciej Chojnicki; Ewelina Kwasniak; Jacek Zielinski
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

5.  Delayed sternal closure after pediatric cardiac operations; single center experience: a retrospective study.

Authors:  Emre Özker; Bülent Saritaş; Can Vuran; Uygar Yörüker; Halim Ulugöl; Riza Türköz
Journal:  J Cardiothorac Surg       Date:  2012-10-02       Impact factor: 1.637

6.  Safety of a 2-Day Antibiotic Regimen After Delayed Chest Closure Post Pediatric Cardiac Surgery.

Authors:  Joseph Philip; Christian Kegg; Dalia Lopez-Colon; Brian J Kelly; Robert M Lawrence; Matthew A Robinson; Ravi S Samraj; Mark S Bleiweis
Journal:  J Intensive Care Med       Date:  2018-08-08       Impact factor: 2.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.